If you’ve been on the lookout for some truly inspiring reads for the young girls (and boys) in your life, you’ve come to ...

Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.

Fintel reports that on March 4, 2025, Citigroup upgraded their outlook for Charles River Laboratories International (NYSE:CRL ...

Citi analyst Patrick Donnelly upgraded Charles River (CRL) to Neutral from Sell with a price target of $175, up from $155. The firm thinks ...

As promised, the restructuring initiatives taking place at Charles River Labs (NYSE: CRL) have resulted in a reduced ...

Charles River's Q4 revenue fell 1.1% to $1B, beating estimates, while adjusted EPS rose to $2.66, surpassing the $2.53 consensus. The company expects 2025 revenue to decline 4.5%-7% and adjusted ...

Throughout the last three months, 6 analysts have evaluated Charles River CRL, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings ...

Conduit Pharmaceuticals and Charles River Laboratories have announced a partnership to evaluate AZD1656, a glucokinase activator, in a preclinical model of systemic lupus erythematosus (SLE).

A woman was rescued from the frigid waters of the Charles River in Cambridge Tuesday morning. The ice rescue happened around 7:45 a.m., according to the Massachusetts State Police Department.